Studies comparing different GLP-1 agonists found that: GLP1s typically produces 14-15.3kg (around 15%) weight loss at higher doses Liraglutide averages 8% weight reduction after 56 weeks Tirzepatide can achieve 20.9% weight loss during initial treatment periods Real-world results often differ from clinical trials, though
Alcohol is not contraindicated with Ozempic, but it amplifies nausea and hypoglycemia risk
Cycle Length Reference Charts Cycling GHK-CU helps maintain receptor sensitivity and prevents potential copper accumulation
PlexusDx's Precision Peptide Genetic Test can reveal predispositions in peptide pathway genesincluding GIPR, FTO, and MC4Rthat may help provide context for conversations with your provider about treatment response expectations and monitoring strategies
By naturally decreasing appetite, this treatment supports sustainable weight loss without extreme diets or intense exercise regimens
Last but not the least, one of the mouse-based studies gave evidence of Melanotan II reversing some of the autistic features (10), but this aspect of study needs more research